Corcept Therapeutics Inc
LSE:0I3Q
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corcept Therapeutics Inc
LSE:0I3Q
|
US |
|
Monster Beverage Corp
NASDAQ:MNST
|
US |
|
T
|
Telstra Corporation Ltd
F:TSTA
|
AU |
|
A
|
Amcor PLC
ASX:AMC
|
UK |
|
Shaanxi Coal Industry Co Ltd
SSE:601225
|
CN |
|
C
|
Caterpillar Inc
XHAM:CAT1
|
US |
|
E
|
Enel SpA
XBER:ENL
|
IT |
|
F
|
First Quantum Minerals Ltd
XBER:IZ1
|
CA |
|
G
|
Goldman Sachs Group Inc
XMUN:GOS
|
US |
|
D
|
DS Smith PLC
SWB:1KR
|
UK |
|
C
|
China Merchants Port Holdings Co Ltd
F:CPM
|
HK |
|
S
|
Siemens Energy AG
OTC:SMNEY
|
DE |
|
Shuangdeng Group Co Ltd
HKEX:6960
|
CN |
|
Roche Holding AG
F:RHO5
|
CH |
|
C
|
China Longyuan Power Group Corp Ltd
F:6WX
|
CN |
|
CGI Inc
TSX:GIB.A
|
CA |
|
C
|
China Life Insurance Co Ltd
F:CLF
|
CN |
|
A
|
Asahi Group Holdings Ltd
XBER:ABW
|
JP |
|
S
|
Steven Madden Ltd
XBER:SJM
|
US |
|
A
|
Aluminum Corp of China Ltd
F:AOC
|
CN |
Wall St Price Targets
0I3Q Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0I3Q is 120.93 USD with a low forecast of 49.98 USD and a high forecast of 171.45 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0I3Q's stock price target?
Price Target
120.93
USD
According to Wall Street analysts, the average 1-year price target for 0I3Q is 120.93 USD with a low forecast of 49.98 USD and a high forecast of 171.45 USD.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
150%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 150%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.
